No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Breast / pathology
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Carcinoma, Intraductal, Noninfiltrating / drug therapy*
-
Carcinoma, Intraductal, Noninfiltrating / genetics*
-
Carcinoma, Intraductal, Noninfiltrating / pathology
-
Carcinoma, Intraductal, Noninfiltrating / surgery
-
Chemotherapy, Adjuvant
-
Clinical Trials as Topic
-
Disease Progression
-
Female
-
Germany
-
Humans
-
Mastectomy, Segmental
-
Neoplasm Invasiveness
-
Neoplasm Staging
-
Prognosis
-
Receptor, ErbB-2 / genetics*
-
Trastuzumab
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Receptor, ErbB-2
-
Trastuzumab